Dela Cerna, Nickson Skyler .

HRN: 25-74-76  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2024
AMPICILLIN 500MG (VIAL)
08/25/2024
09/01/2024
IV
340mg
Q6
PCAP C
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  PneumoniaBloodstreamEye, Ear, Nose, Throat, & MouthProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: